Plasmalogen Supplements
Just like every disease is linked to a negative, biochemical deficiency prodrome, your vital operating systems are linked to a positive, biochemical reserve prodrome. Strategic biochemical reserves can be created with plasmalogen supplementation to help the body maintain vitality, resist the entropy of aging, and achieve longevity.
Prodrome plasmalogen supplements contain 100-900x more plasmalogen than other plasmalogen supplement brands available! Dr. Dayan Goodenowe - a biochemist, neuroscientist, synthetic organic chemist, and author of Breaking Alzheimer's: A 15 Year Crusade to Expose the Cause and Deliver the Cure - has scientifically designed the plasmalogen supplements to replenish certain deficiencies in key molecules identified by the ProdromeScan plasmalogen blood test.
“We don’t fully understand what dictates an individual’s natural plasmalogen levels, but we want to bring everyone up to that higher level, and we think that can be done through dietary supplementation,” Professor Peter Meikle said in Alzheimer's & Dementia: The Journal of the Alzheimer's Association. “Given the global scale of Alzheimer’s disease, we see a simple lipid supplement as something that could potentially help millions.” It’s hoped that this type of oral supplementation may also help with the prevention of other common metabolic diseases such as fatty liver disease and heart attacks, where Professor Meikle’s team has also determined plasmalogens play a protective role.
Prodrome Neuro
ProdromeNeuro (oil and capsules) specifically provides the building blocks for neuronal fatty acid plasmalogens to restore, maintain, and optimize neuron membranes, and to create a biochemical reserve of critical membrane building material for neuron membrane repair when needed.
Prodrome GTA
As persons get older, they become more likely to be deficient in GTAs (gastrointestinal tract acids). Low levels are linked to increased risk of colorectal cancer and pancreatic cancer. Currently there is no well-established way to elevate GTA levels in deficient persons. The best naturally occurring plant extract that possesses similar biochemical properties as GTAs is a curcuminoid called BDMC. However, naturally occurring BDMC levels are only a very small percentage of normal curcuminoid supplements.
ProdromeGTA (capsules) contains a patented BDMC formulation that delivers the highest concentration of BDMC available which is 10-100x the amount found in typical curcuminoid supplements, and mimics activity that compensates for a gastrointestinal tract acid (GTA) deficiency.
Prodrome Glia
Glia are the cells in your brain and spinal cord that surround, support, protect, and insulate neurons, commonly referred to as white matter. Inflammation-mediated diseases like autism and multiple sclerosis as well as cerebrovascular and cardiovascular disease attack and degrade white matter.
ProdromeGlia (oil and capsules) is a biochemical plasmalogen supplement specifically designed to provide the omega-9 plasmalogen building blocks that white matter glia cells need to restore, maintain, and optimize glia membranes, and to create a biochemical reserve of critical membrane building material for glia membrane repair when needed.
COntact your health Care provider to order the supplements
PLASMALOGEN SUPPLEMENT PUBLICATIONS
Plasmalogen deficiency and neuropathology in Alzheimer’s disease: Causation or coincidence? Alzheimer’s & Dementia TRCI 5: Doi 10.1016/j.trci.2019.08.003
Relation of Serum Plasmalogens and APOE Genotype to Cognition and Dementia in Older Persons in a Cross-Sectional Study. Brain Sci 9: Doi 10.3390/brainsci9040092
Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice. PLoS One. 2016 Mar 9;11(3):e0151020. doi: 10.1371/journal.pone.0151020.
Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study. BMC neurology, 15, 154. doi:10.1186/s12883-015-0411-4
Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys. Behav Brain Res. 2015 Jun 1;286:328-37. doi: 10.1016/j.bbr.2015.03.012.
Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer’s disease. Lipids in health and disease, 10, 227. doi:10.1186/1476-511X-10-227